Glazer Capital, LLC's Form 4 filing
Revelation Biosciences, Inc. (REVB) · filed Sep 23, 2021
- Accession no.
- 0001076809-21-000221
- Filed
- Sep 23, 2021, 4:21 PM ET
- Trade date
- Sep 21-23, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $6.60M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Glazer Capital, LLCCIK 0001076809 | 10% Owner |
| Glazer Paul JCIK 0001133985 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2021 | Common stock, $0.001 par value per share | SSaleDisposed | −43,000 | $10.08 | −$433,440 | 992,652 | Indirect | |
| Sep 22, 2021 | Common stock, $0.001 par value per share | SSaleDisposed | −5 | $10.08 | −$50.4 | 992,647 | Indirect | |
| Sep 23, 2021 | Common stock, $0.001 par value per share | SSaleDisposed | −611,541 | $10.08 | −$6,164,333.28 | 381,106 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.